Filing Details
- Accession Number:
- 0001013762-23-003901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-13 18:56:56
- Reporting Period:
- 2023-10-13
- Accepted Time:
- 2023-10-13 18:56:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1788028 | Jasper Therapeutics Inc. | JSPR | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1574558 | William Lis | C/O Jasper Therapeutics, Inc. 2200 Bridge Pkwy, Suite #102 Redwood City CA 94065 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Voting Common Stock | Disposition | 2023-10-13 | 7,965 | $0.85 | 53,521 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a trading plan intended to comply with Rule 10b5-1(c) and adopted by the Reporting Person on June 15, 2023.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.84 to $0.8717, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price.